Jayamas Medica Industri Stock Profit Margin
| OMED Stock | 184.00 1.00 0.54% |
Jayamas Medica Industri fundamentals help investors to digest information that contributes to Jayamas Medica's financial success or failures. It also enables traders to predict the movement of Jayamas Stock. The fundamental analysis module provides a way to measure Jayamas Medica's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Jayamas Medica stock.
Jayamas |
Jayamas Medica Industri Company Profit Margin Analysis
Jayamas Medica's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Jayamas Medica Profit Margin | 0.24 % |
Most of Jayamas Medica's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Jayamas Medica Industri is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Jayamas Medica Industri has a Profit Margin of 0.2363%. This is 102.11% lower than that of the Healthcare sector and 101.31% lower than that of the Medical Instruments & Supplies industry. The profit margin for all Indonesia stocks is 118.61% lower than that of the firm.
Jayamas Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Jayamas Medica's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Jayamas Medica could also be used in its relative valuation, which is a method of valuing Jayamas Medica by comparing valuation metrics of similar companies.Jayamas Medica is rated below average in profit margin category among its peers.
Jayamas Fundamentals
| Return On Equity | 0.52 | |||
| Return On Asset | 0.29 | |||
| Profit Margin | 0.24 % | |||
| Operating Margin | 0.31 % | |||
| Current Valuation | 5.63 T | |||
| Shares Outstanding | 27.06 B | |||
| Shares Owned By Insiders | 8.00 % | |||
| Shares Owned By Institutions | 0.47 % | |||
| Price To Book | 5.55 X | |||
| Price To Sales | 2.76 X | |||
| Revenue | 2.19 T | |||
| Gross Profit | 904.29 B | |||
| EBITDA | 697.78 B | |||
| Net Income | 562.69 B | |||
| Book Value Per Share | 46.00 X | |||
| Cash Flow From Operations | 505.11 B | |||
| Earnings Per Share | 16.47 X | |||
| Number Of Employees | 1.03 K | |||
| Market Capitalization | 5.9 T | |||
| Last Dividend Paid | 10.87 |
About Jayamas Medica Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Jayamas Medica Industri's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jayamas Medica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jayamas Medica Industri based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Jayamas Stock
Jayamas Medica financial ratios help investors to determine whether Jayamas Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jayamas with respect to the benefits of owning Jayamas Medica security.